0
     

Report Added
Report already added
Europe In Vitro Diagnostics (IVD) Market 2021-2031 by Product (Instruments & Devices, Reagents & Kits, Software & Services), Technology (Clinical Chemistry, Molecular Diagnostics, Immuno Diagnostics), Sample Type (Blood, Mucus, Urine), Application (Infectious Diseases, Diabetes, Cancer/Oncology), End User (Diagnostic Labs, Hospitals and Clinics, Homecare, POC), and Country: Trend Forecast and Growth Opportunity

Europe In Vitro Diagnostics (IVD) Market 2021-2031 by Product (Instruments & Devices, Reagents & Kits, Software & Services), Technology (Clinical Chemistry, Molecular Diagnostics, Immuno Diagnostics), Sample Type (Blood, Mucus, Urine), Application (Infectious Diseases, Diabetes, Cancer/Oncology), End User (Diagnostic Labs, Hospitals and Clinics, Homecare, POC), and Country: Trend Forecast and Growth Opportunity

Europe in vitro diagnostics (IVD) market was valued at $ 21,682.6 million in 2021 and will grow by 6.5% annually over 2021-2031, driven by the increasing prevalence of chronic diseases along with the growing geriatric population, burgeoning demand for automation in diagnostics, the rising development of condition-specific treatment and booming awareness regarding personalized medicines, emergence of minimally invasive and non-invasive diagnostics tools & techniques, the rising healthcare expenditure, and rise in the demand for POC testing.
Highlighted with 35 tables and 64 figures, this 138-page report “Europe In Vitro Diagnostics (IVD) Market 2021-2031 by Product (Instruments & Devices, Reagents & Kits, Software & Services), Technology (Clinical Chemistry, Molecular Diagnostics, Immuno Diagnostics), Sample Type (Blood, Mucus, Urine), Application (Infectious Diseases, Diabetes, Cancer/Oncology), End User (Diagnostic Labs, Hospitals and Clinics, Homecare, POC), and Country: Trend Forecast and Growth Opportunity” is based on a comprehensive research of the entire Europe in vitro diagnostics (IVD) market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2018-2021 and provides forecast from 2022 till 2031 with 2021 as the base year. (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)

In-depth qualitative analyses include identification and investigation of the following aspects:
•Market Structure
•Growth Drivers
•Restraints and Challenges
•Emerging Product Trends & Market Opportunities
•Porter’s Fiver Forces
The trend and outlook of Europe market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19 and Russia-Ukraine conflict. The balanced (most likely) projection is used to quantify Europe in vitro diagnostics (IVD) market in every aspect of the classification from perspectives of Product, Technology, Sample Type, Application, End User, and Country.

Based on Product, the Europe market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.
•Instruments & Devices
oDisposable IVD Devices
oReusable IVD Devices
•Reagents & Kits
•Software & Services

Based on Technology, the Europe market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.
•Clinical Chemistry
•Molecular Diagnostics
•Immuno Diagnostics
•Hematology
•Tissue Diagnostics
•Microbiology
•Coagulation and Hemostasis
•Urinalysis
•Other Technologies

By Sample Type, the Europe market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.
•Blood
•Mucus
•Urine
•Other Sample Types

By Application, the Europe market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.
•Infectious Diseases
•Diabetes
•Cancer/Oncology
•Cardiology
•Autoimmune Disease
•Nephrology
•Drug Testing
•HIV/AIDS
•Other Applications

By End User, the Europe market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.
•Diagnostic Laboratories
•Hospitals and Clinics
•Homecare Settings
•Point-of-Care (POC) Settings
•Other End Users

Geographically, the following national/local markets are fully investigated:
•Germany
•UK
•France
•Spain
•Italy
•Netherlands
•Rest of Europe (further segmented into Russia, Switzerland, Poland, Sweden, Belgium, Austria, Ireland, Norway, Denmark, and Finland)
For each key country, detailed analysis and data for annual revenue ($ mn) are available for 2021-2031. The breakdown of national markets by Product, Application and End User over the forecast years are also included.

The report also covers current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players.
Selected Key Players:
Abbott Laboratories, Inc.
Agilent Technologies, Inc.
Arkray Inc.
Becton, Dickinson and Company
Biomerieux SA
Bio-Rad Laboratories Inc.
Danaher Corporation
DiaSorin SpA (Luminex Corporation)
Epic Systems Corporation
F. Hoffmann-La Roche Ltd.
Genpact Limited
Grifols SA
IBM Corporation
Mckesson Corporation
Ortho Clinical Diagnostics Inc.
Qiagen NV
Quest Diagnostics Inc.
Quidel Corporation
Roche Diagnostics
Siemens Healthineers
Sysmex Corporation
Thermo Fisher Scientific Inc.
(Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)
Table of Contents

1 Introduction7
1.1 Industry Definition and Research Scope7
1.1.1 Industry Definition7
1.1.2 Research Scope8
1.2 Research Methodology11
1.2.1 Overview of Market Research Methodology11
1.2.2 Market Assumption12
1.2.3 Secondary Data12
1.2.4 Primary Data12
1.2.5 Data Filtration and Model Design13
1.2.6 Market Size/Share Estimation14
1.2.7 Research Limitations15
1.3 Executive Summary16
2 Market Overview and Dynamics19
2.1 Market Size and Forecast19
2.1.1 Impact of COVID-19 on World Economy20
2.1.2 Impact of COVID-19 on the Market24
2.2 Major Growth Drivers26
2.3 Market Restraints and Challenges32
2.4 Emerging Opportunities and Market Trends35
2.5 Porter’s Fiver Forces Analysis39
3 Segmentation of Europe Market by Product43
3.1 Market Overview by Product43
3.2 Instruments & Devices45
3.2.1 Disposable IVD Devices46
3.2.2 Reusable IVD Devices47
3.3 Reagents & Kits48
3.4 Software & Services49
4 Segmentation of Europe Market by Technology50
4.1 Market Overview by Technology50
4.2 Clinical Chemistry52
4.3 Molecular Diagnostics53
4.4 Immuno Diagnostics54
4.5 Hematology55
4.6 Tissue Diagnostics56
4.7 Microbiology57
4.8 Coagulation and Hemostasis58
4.9 Urinalysis59
4.10 Other Technologies60
5 Segmentation of Europe Market by Sample Type61
5.1 Market Overview by Sample Type61
5.2 Blood63
5.3 Mucus64
5.4 Urine65
5.5 Other Sample Types66
6 Segmentation of Europe Market by Application67
6.1 Market Overview by Application67
6.2 Infectious Diseases69
6.3 Diabetes79
6.4 Cancer/Oncology80
6.5 Cardiology81
6.6 Autoimmune Disease82
6.7 Nephrology83
6.8 Drug Testing84
6.9 HIV/AIDS85
6.10 Other Applications86
7 Segmentation of Europe Market by End User87
7.1 Market Overview by End User87
7.2 Diagnostic Laboratories89
7.3 Hospitals and Clinics90
7.4 Homecare Settings91
7.5 Point-of-Care (POC) Settings92
7.6 Other End Users93
8 European Market 2021-2031 by Country94
8.1 Overview of European Market94
8.2 Germany97
8.3 U.K.99
8.4 France101
8.5 Spain103
8.6 Italy105
8.7 Netherlands107
8.8 Rest of European Market109
9 Competitive Landscape111
9.1 Overview of Key Vendors111
9.2 New Product Launch, Partnership, Investment, and M&A114
9.3 Company Profiles115
Abbott Laboratories, Inc.115
Agilent Technologies, Inc.117
Arkray Inc.118
Becton, Dickinson and Company119
Biomerieux SA120
Bio-Rad Laboratories Inc.121
Danaher Corporation122
DiaSorin SpA (Luminex Corporation)123
Epic Systems Corporation124
F. Hoffmann-La Roche Ltd.125
Genpact Limited126
Grifols SA127
IBM Corporation128
Mckesson Corporation129
Ortho Clinical Diagnostics Inc.130
Qiagen NV131
Quest Diagnostics Inc.132
Quidel Corporation133
Roche Diagnostics134
Siemens Healthineers135
Sysmex Corporation136
Thermo Fisher Scientific Inc.137
RELATED REPORTS138List of Tables:

Table 1. Snapshot of Europe In Vitro Diagnostics Market in Balanced Perspective, 2021-203117
Table 2. World Economic Outlook, 2021-203121
Table 3. World Economic Outlook, 2021-202322
Table 4. World Health Spending by Region, $ bn, 2013-202031
Table 5. Main Product Trends and Market Opportunities in Europe In Vitro Diagnostics Market35
Table 6. Europe In Vitro Diagnostics Market by Product, 2021-2031, $ mn43
Table 7. Europe In Vitro Diagnostics Market: Instruments & Devices by Type, 2021-2031, $ mn45
Table 8. Europe In Vitro Diagnostics Market by Technology, 2021-2031, $ mn50
Table 9. Europe In Vitro Diagnostics Market by Sample Type, 2021-2031, $ mn61
Table 10. Europe In Vitro Diagnostics Market by Application, 2021-2031, $ mn67
Table 11. Commercially Available COVID-19 Diagnostic Tests Approved in 2021-202270
Table 12. Europe In Vitro Diagnostics Market by End User, 2021-2031, $ mn87
Table 13. Europe In Vitro Diagnostics Market by Country, 2021-2031, $ mn96
Table 14. Germany In Vitro Diagnostics Market by Product, 2021-2031, $ mn98
Table 15. Germany In Vitro Diagnostics Market by Sample Application, 2021-2031, $ mn98
Table 16. Germany In Vitro Diagnostics Market by End User, 2021-2031, $ mn98
Table 17. U.K. In Vitro Diagnostics Market by Product, 2021-2031, $ mn100
Table 18. U.K. In Vitro Diagnostics Market by Sample Application, 2021-2031, $ mn100
Table 19. U.K. In Vitro Diagnostics Market by End User, 2021-2031, $ mn100
Table 20. France In Vitro Diagnostics Market by Product, 2021-2031, $ mn102
Table 21. France In Vitro Diagnostics Market by Sample Application, 2021-2031, $ mn102
Table 22. France In Vitro Diagnostics Market by End User, 2021-2031, $ mn102
Table 23. Spain In Vitro Diagnostics Market by Product, 2021-2031, $ mn104
Table 24. Spain In Vitro Diagnostics Market by Sample Application, 2021-2031, $ mn104
Table 25. Spain In Vitro Diagnostics Market by End User, 2021-2031, $ mn104
Table 26. Italy In Vitro Diagnostics Market by Product, 2021-2031, $ mn106
Table 27. Italy In Vitro Diagnostics Market by Sample Application, 2021-2031, $ mn106
Table 28. Italy In Vitro Diagnostics Market by End User, 2021-2031, $ mn106
Table 29. Netherlands In Vitro Diagnostics Market by Product, 2021-2031, $ mn108
Table 30. Netherlands In Vitro Diagnostics Market by Sample Application, 2021-2031, $ mn108
Table 31. Netherlands In Vitro Diagnostics Market by End User, 2021-2031, $ mn108
Table 32. In Vitro Diagnostics Market in Rest of Europe by Country, 2021-2031, $ mn110
Table 33. Abbott Laboratories, Inc.: Company Snapshot115
Table 34. Abbott Laboratories, Inc.: Business Segmentation116
Table 35. Abbott Laboratories, Inc.: Product Portfolio116

Report Title: Europe In Vitro Diagnostics (IVD) Market 2021-2031 by Product (Instruments & Devices, Reagents & Kits, Software & Services), Technology (Clinical Chemistry, Molecular Diagnostics, Immuno Diagnostics), Sample Type (Blood, Mucus, Urine), Application (Infectious Diseases, Diabetes, Cancer/Oncology), End User (Diagnostic Labs, Hospitals and Clinics, Homecare, POC), and Country: Trend Forecast and Growth Opportunity


Your Details
Valid Invalid number

SELECT A FORMAT

ADD TO CART BUY NOW

Related Report

2023 What's Next for Vietnam Diagnostics Market?--2022 Supplier Shares and Strategies, 2022-2027 Volume and Sales Forecasts for 500 Tests--Blood Banking, Cancer Diagnostics, Clinical Chemistry, Coagulation, Drugs of Abuse, Endocrine Function, Flow Cytometry, Hematology, Immunoproteins, Infectious Diseases, Molecular Diagnostics, TDM

2023 What's Next for Vietnam Diagnostics Market?--2022 Supplier Shares and Strategies, 2022-2027 Volume and Sales Forecasts for 500 Tests--Blood Banking, Cancer Diagnostics, Clinical Chemistry, Coagulation, Drugs of Abuse, Endocrine Function, Flow Cytometry, Hematology, Immunoproteins, Infectious Diseases, Molecular Diagnostics, TDM

2023 What's Next for Venezuela Diagnostics Market?--2022 Supplier Shares and Strategies, 2022-2027 Volume and Sales Forecasts for 500 Tests--Blood Banking, Cancer Diagnostics, Clinical Chemistry, Coagulation, Drugs of Abuse, Endocrine Function, Flow Cytometry, Hematology, Immunoproteins, Infectious Diseases, Molecular Diagnostics, TDM

2023 What's Next for Venezuela Diagnostics Market?--2022 Supplier Shares and Strategies, 2022-2027 Volume and Sales Forecasts for 500 Tests--Blood Banking, Cancer Diagnostics, Clinical Chemistry, Coagulation, Drugs of Abuse, Endocrine Function, Flow Cytometry, Hematology, Immunoproteins, Infectious Diseases, Molecular Diagnostics, TDM

2023 What's Next for US Diagnostics Market?--2022 Supplier Shares and Strategies, 2022-2027 Volume and Sales Forecasts for 500 Tests--Blood Banking, Cancer Diagnostics, Clinical Chemistry, Coagulation, Drugs of Abuse, Endocrine Function, Flow Cytometry, Hematology, Immunoproteins, Infectious Diseases, Molecular Diagnostics, TDM

2023 What's Next for US Diagnostics Market?--2022 Supplier Shares and Strategies, 2022-2027 Volume and Sales Forecasts for 500 Tests--Blood Banking, Cancer Diagnostics, Clinical Chemistry, Coagulation, Drugs of Abuse, Endocrine Function, Flow Cytometry, Hematology, Immunoproteins, Infectious Diseases, Molecular Diagnostics, TDM

2023 What's Next for Uruguay Diagnostics Market?--2022 Supplier Shares and Strategies, 2022-2027 Volume and Sales Forecasts for 500 Tests--Blood Banking, Cancer Diagnostics, Clinical Chemistry, Coagulation, Drugs of Abuse, Endocrine Function, Flow Cytometry, Hematology, Immunoproteins, Infectious Diseases, Molecular Diagnostics, TDM

2023 What's Next for Uruguay Diagnostics Market?--2022 Supplier Shares and Strategies, 2022-2027 Volume and Sales Forecasts for 500 Tests--Blood Banking, Cancer Diagnostics, Clinical Chemistry, Coagulation, Drugs of Abuse, Endocrine Function, Flow Cytometry, Hematology, Immunoproteins, Infectious Diseases, Molecular Diagnostics, TDM

2023 What's Next for United Arab Emirates Diagnostics Market?--2022 Supplier Shares and Strategies, 2022-2027 Volume and Sales Forecasts for 500 Tests--Blood Banking, Cancer Diagnostics, Clinical Chemistry, Coagulation, Drugs of Abuse, Endocrine Function, Flow Cytometry, Hematology, Immunoproteins, Infectious Diseases, Molecular Diagnostics, TDM

2023 What's Next for United Arab Emirates Diagnostics Market?--2022 Supplier Shares and Strategies, 2022-2027 Volume and Sales Forecasts for 500 Tests--Blood Banking, Cancer Diagnostics, Clinical Chemistry, Coagulation, Drugs of Abuse, Endocrine Function, Flow Cytometry, Hematology, Immunoproteins, Infectious Diseases, Molecular Diagnostics, TDM

2023 What's Next for Ukraine Diagnostics Market?--2022 Supplier Shares and Strategies, 2022-2027 Volume and Sales Forecasts for 500 Tests--Blood Banking, Cancer Diagnostics, Clinical Chemistry, Coagulation, Drugs of Abuse, Endocrine Function, Flow Cytometry, Hematology, Immunoproteins, Infectious Diseases, Molecular Diagnostics, TDM

2023 What's Next for Ukraine Diagnostics Market?--2022 Supplier Shares and Strategies, 2022-2027 Volume and Sales Forecasts for 500 Tests--Blood Banking, Cancer Diagnostics, Clinical Chemistry, Coagulation, Drugs of Abuse, Endocrine Function, Flow Cytometry, Hematology, Immunoproteins, Infectious Diseases, Molecular Diagnostics, TDM